Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Albert Bourla
Pharma
Pfizer cranks up revenue outlook amid Paxlovid sales bump
The company is projecting yearly sales of $61 billion to $64 billion in a $1.5 billion boost from previous forecasts.
Zoey Becker
Oct 29, 2024 10:40am
UPDATED: Starboard wants to hold Pfizer leadership 'accountable'
Oct 22, 2024 11:01am
Activist investor accuses Pfizer of threatening former execs
Oct 10, 2024 11:01am
Pfizer CEO Bourla to meet with activist investor Starboard: FT
Oct 9, 2024 11:49am
The top 10 best-paid CEOs in Big Pharma in 2023
Jun 17, 2024 3:00am
Pfizer to press pause on large M&A deals, CEO says
Jun 11, 2024 10:50am
